Perspective Therapeutics, Inc.
CATXAMEXHealthcare● Active
$2.93
$-0.10(-3.30%)
Market Cap$226342500
P/E Ratio—
52W High$6.16
52W Low$1.96
Perspective Therapeutics, Inc.（CATX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CATX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2022-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | 100.00% | 23.00% | 42.76% |
| Operating Expenses | |||||
| R&D Expenses | $0.08B | $0.04B | $0.02B | $0.00B | $0.00B |
| G&A Expenses | $0.03B | $0.03B | $0.02B | $0.01B | $0.01B |
| Total Operating Expenses | $0.11B | $0.09B | $0.04B | $0.02B | $0.01B |
| Operating Income | ($0.11B) | $0.01B | ($0.04B) | ($0.02B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | -213.71% | -68.47% |
| Interest Income | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.10B) | ($0.08B) | ($0.04B) | ($0.01B) | ($0.01B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Net Income | ($0.10B) | ($0.08B) | ($0.05B) | ($0.01B) | ($0.01B) |
| Net Margin %(computed) | — | — | — | -206.50% | -66.26% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.40 | $-1.23 | $-0.85 | $-0.27 | $-0.13 |
| Wtd Avg Shares | 0.07B | 0.06B | 0.05B | 0.05B | 0.05B |
| EBITDA | ($0.10B) | $0.01B | ($0.04B) | ($0.01B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — | -208.87% | -68.47% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Perspective Therapeutics, Inc.
关于Perspective Therapeutics, Inc.（CATX）损益表
Perspective Therapeutics, Inc.（CATX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CATX实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.10B)（净利率—）。
常见问题
CATX · 4 问Perspective Therapeutics, Inc.（CATX）2025财年营收为$0.00B，同比down—%。
CATX revenueCATX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08